Nils Schoof
Bayer (Germany)(DE)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Menopause: Health Impacts and Treatments, Systemic Sclerosis and Related Diseases, Lymphoma Diagnosis and Treatment, Estrogen and related hormone effects
Most-Cited Works
- → Large-scale genotyping identifies 41 new loci associated with breast cancer risk(2013)1,100 cited
- → Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer(2013)537 cited
- → Genome-wide association studies identify four ER negative–specific breast cancer risk loci(2013)418 cited
- → Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors(2013)165 cited
- → The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review(2018)105 cited
- → STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis(2005)94 cited
- → Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes(2014)68 cited
- → Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort(2016)66 cited
- → Humanistic and cost burden of systemic sclerosis: A review of the literature(2017)61 cited
- → HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells(2009)60 cited